- Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study2013 | Publikace bez příslušnosti k fakultě
- Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospective, and Randomized Study2009 | Publikace bez příslušnosti k fakultě
- Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention2011 | Publikace bez příslušnosti k fakultě
- The prognostic significance of periprocedural infarction in the era of potent antithrombotic therapy. The PRAGUE-18 substudy2020 | 1. lékařská fakulta, 3. lékařská fakulta, Ústřední knihovna
- Effect of Rosuvastatin Therapy on Troponin I Release Following Percutaneous Coronary Intervention in Nonemergency Patients (from the TIP 3 Study)2014 | Lékařská fakulta v Plzni
- Comparison of Carotid Artery Stenting in Patients With Single Versus Bilateral Carotid Artery Disease and Factors Affecting Midterm Outcome2011 | Publikace bez příslušnosti k fakultě
- Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-82008 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Pre-percutaneous coronary intervention statin therapy: Is it necessary?2014 | Publikace bez příslušnosti k fakultě
- Prevalence and predictors of coronary artery disease in patients undergoing carotid artery stenting2019 | 3. lékařská fakulta